Northern Trust
FNCH

Northern Trust’s Finch Therapeutics Group, Inc. Common Stock FNCH Stock Holding History

Northern Trust’s Portfolio FNCH Stock Details FNCH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-842
Closed -$9.93K – 4627
2023
Q1 		$9.93K Hold
842
– – ﹤0.01% 4525
2022
Q4 		$12.1K Hold
842
– – ﹤0.01% 4553
2022
Q3 		$42K Buy
842
+367
+77% +$25.5K ﹤0.01% 4371
2022
Q2 		$40K Sell
475
-1,686
-78% -$144K ﹤0.01% 4470
2022
Q1 		$326K Sell
2,161
-87
-4% -$20.1K ﹤0.01% 3916
2021
Q4 		$672K Sell
2,248
-62
-3% -$23.8K ﹤0.01% 3700
2021
Q3 		$901K Sell
2,310
-225
-9% -$95.9K ﹤0.01% 3586
2021
Q2 		$1.07M Buy
+2,535
New +$1.1M ﹤0.01% 3512

Other funds holding FNCH

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

Northern Trust's FNCH Position: Q2 2023 in Review

Northern Trust sold out of Finch Therapeutics Group, Inc. Common Stock (FNCH) in Q2 2023, closing a stake of 842 shares — an estimated $9.93K sold.

Northern Trust first reported a position in FNCH in Q2 2021 and held it in 8 quarters. The position peaked at $1.07M in Q2 2021. 17 funds tracked by Wall St. Rank hold FNCH as of Q2 2023.

  • Northern Trust reported no remaining Finch Therapeutics Group, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Northern Trust sold 842 Finch Therapeutics Group, Inc. Common Stock shares in Q2 2023, an estimated $9.93K.
  • Northern Trust first reported a position in Finch Therapeutics Group, Inc. Common Stock in Q2 2021 and held it in 8 quarters.
  • Northern Trust's Finch Therapeutics Group, Inc. Common Stock position peaked at $1.07M in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Finch Therapeutics Group, Inc. Common Stock as of Q2 2023.

Based on Northern Trust's 13F filing for Q2 2023, filed 11 Aug 2023.